Share on LinkedInShare on LinkedIn

ARTICLE · 22 JANUARY 2024

USPTO Issues Enablement Guidelines Following Amgen v. Sanofi

On January 10, 2024, the United States Patent and Trademark Office (USPTO) released Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court...

United StatesIntellectual Property

On January 10, 2024, the United States Patent and Trademark Office (USPTO) released Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. Sanofi et al.12 The Guidelines are intended to inform U.S. patent examiners and the public about the process to be followed when assessing whether a claim satisfies the enablement requirement under 35 U.S.C. 112(a), after the U.S. Supreme Court's holding in Amgen v. Sanofi.3

35 U.S.C. §112(a)

The enablement requirement under 35 U.S.C. 112(a) is met as to a particular claim of a patent or application when that claim is "supported" by the patent or application disclosure. If it can be demonstrated that the patent disclosure as filed contained sufficient information about the subject matter of the claim so as to enable one skilled in the pertinent art to make and use the claimed invention without "undue experimentation," the claim is enabled. The

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from